GMO Beyond China ETF (NYSEARCA:BCHI) Sees Large Increase in Short Interest

GMO Beyond China ETF (NYSEARCA:BCHIGet Free Report) was the target of a large growth in short interest in the month of May. As of May 29th, there was short interest totaling 2,684 shares, a growth of 800.7% from the May 14th total of 298 shares. Based on an average daily trading volume, of 1,923 shares, the days-to-cover ratio is presently 1.4 days. Approximately 0.5% of the company’s stock are short sold.

Institutional Investors Weigh In On GMO Beyond China ETF

An institutional investor recently bought a new position in GMO Beyond China ETF stock. Lazard Asset Management LLC bought a new position in GMO Beyond China ETF (NYSEARCA:BCHIFree Report) in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 20,851 shares of the company’s stock, valued at approximately $570,000. Lazard Asset Management LLC owned 5.21% of GMO Beyond China ETF at the end of the most recent quarter.

GMO Beyond China ETF Trading Up 4.1%

Shares of BCHI stock opened at $39.81 on Friday. GMO Beyond China ETF has a twelve month low of $26.14 and a twelve month high of $41.94. The stock has a market capitalization of $19.91 million, a price-to-earnings ratio of 14.75 and a beta of 1.06. The stock has a fifty day simple moving average of $37.59 and a two-hundred day simple moving average of $34.04.

GMO Beyond China ETF Company Profile

(Get Free Report)

The GMO Beyond China ETF (BCHI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed to invest in equity securities of any market capitalization from emerging markets, with the exemption of China. BCHI was launched on Feb 12, 2025 and is issued by GMO.

Further Reading

Receive News & Ratings for GMO Beyond China ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO Beyond China ETF and related companies with MarketBeat.com's FREE daily email newsletter.